Low-level light therapy for dry eye & skin pigmentation
Part of Eyes & vision clinical trials.
This study tests whether low-level light therapy can improve dry eye symptoms caused by blocked oil glands (Meibomian Gland Dysfunction). It also looks at how the treatment affects skin pigmentation under the eyes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to read and understand English consent forms.
- You must have signs or symptoms of Meibomian Gland Dysfunction (MGD), like poor oil quality in tears or blocked oil glands.
- You cannot have active eye infections, Sjogren's syndrome, or have had eye surgery in the past 6 months.
- You cannot have had certain dry eye treatments (like LipiFlow or IPL) in the last 12 months.
- You cannot be taking light-sensitive medications, be pregnant or breastfeeding, or have skin issues around your eyes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether low-level light therapy can improve dry eye disease by measuring changes in tear proteins. It may help people with chronic dry eye who are interested in a non-drug treatment.
This study tests whether TearCare, a device that warms and massages the eyelids, can help young adults with dry eyes caused by blocked oil glands. The trial measures whether the treatment improves tear quality and eye comfort.
This study tests two types of light therapy—low-level light therapy (LLLT) and intense pulsed light (IPL)—to see which one might better prevent dry eye from developing after cataract surgery. It is for people age 50+ who are having both eyes operated on and do not currently have dry eye.
This study tests whether a special light (photobiomodulation) using red or blue light can help people with dry eye that is caused by both blocked oil glands and tiny eyelash mites. You'd receive 3 treatments, and we'd check how your eyes feel for a month after.
This trial tests a non-invasive radiofrequency treatment for people with meibomian gland dysfunction (a type of dry eye) that hasn't improved with standard treatments. It aims to see if this therapy can safely help your eyes feel better.
This trial tests whether a special light treatment (photobiomodulation) can help people with dry age-related macular degeneration (AMD). It is designed for those with early to moderate dry AMD who still have fairly good vision.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.